Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
NCT00388154Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2004
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, cisplatin in endometrial cancer (EC), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2004; status: completed.
02
Drugs
gemcitabinecisplatin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00388154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00388154.